A technique to get more information from the blood of cancer patients than previously possible has been developed.
The discovery could potentially accelerate early diagnosis, speed up drug discovery and lead to advancements in personalized medicines. The Cancer Research UK-funded study is published in Advanced Materials today (Wednesday).
The scientists, from the University of Manchester, collected blood samples from women with advanced ovarian cancer who were treated with a type of chemotherapy called CAELYX®. This chemotherapy drug is contained in a soft, lipid-based nanoparticle, called a liposome, which acts as a vessel to help minimize side effects.